Brussels, 19/10/2005 (Agence Europe) - The Swiss laboratory Roche announced on 18 October that it would further extend its production capacity of the anti-viral drug oseltamivir, which is sold under the name Tamiflu. The press release issued by the company points out that animal tests have shown that the drug is effective against the bird flu virus H5N1. It adds that Roche intends to satisfy all demand, which has seen a huge increase since a number of countries decided to stockpile this...